Vitrafy Life Sciences Limited (ASX: VFY) is a Melbourne-based life sciences company offering a fully integrated cryopreservation solution via its proprietary hardware and cloud-based software platform, LifeChain™. Listed on the ASX on 6 November 2024, Vitrafy has been swift in translating its IPO capital into tangible milestones in both technological development and early commercial traction.

Cuscal Limited (ASX: CCL) is a name that has quietly underpinned the digital payments infrastructure of Australia for decades. After officially listing on the ASX on 25 November 2024, Cuscal is now navigating the next chapter of its 60-year journey — building on its foundation as one of the nation’s leading independent B2B payments and data service providers.

Mount Hope Mining Limited (ASX: MHM) is a newly listed exploration company focused on copper and gold in the Southern Cobar Basin of New South Wales. With a 175km² strategic landholding and a well-connected location in an established mining region, the company is positioning itself within a district known for its polymetallic endowment and historic production.

This is our second Samso Radar - Weekly Review, and this week we are looking at the Health Care sector on the ASX. The timing may be now for investors to take notice and understand the ASX Healthcare sector as some signs are showing that a counter-cyclical opportunity may be in play in 2025. Timing is the key and this Samso Radar Weekly Review may be the beginning the understanding process.

ReNerve Limited (ASX: RNV) listed on the ASX in July 2023, positioning itself as a commercial-stage medtech company aiming to transform nerve repair through innovative tissue-engineered solutions. Less than two years later, the company has demonstrated consistent momentum in bringing its products to market, establishing international distribution networks, and expanding its product pipeline.

Fulcrum Lithium Ltd (ASX: FUL) has entered the ASX stage with ambitions as large as its Nevada lithium portfolio. Since its IPO in November 2024, Fulcrum has maintained a sharp operational pace, demonstrating early exploration success and strategic clarity across three key lithium projects—Alkali Flats, Fairway, and Summit

A rare opportunity for investors seeking a consistent stream of franked monthly income, coupled with capital preservation and long-term growth.

When it comes to transforming cancer care, true innovation lies not just in killing the cancer, but in seeing it and feeling it less, and healing with more grace. In this quiet revolution, Invion Limited (ASX: IVX) is emerging as a serious contender.

As an exploration geologist, the Hamersley iron story has always fascinated me. For decades, we’ve treated the timeline of iron ore formation in the Pilbara’s Hamersley Province as almost gospel. We referenced phosphate dating and clast-bearing conglomerates as reliable benchmarks. But what happens when new geochronological tools rip apart that foundation?

Is Rumble Resources Limtied (ASX: RTR) a gold story that should be promoting itself more as a tungsten critical mineral conversation. As the tungsten narrative makes it move to be the king of the critical mienral list, one need to consider this story like the Delta Lithium (previusly Red Dirt Metals Limited (ASX:RDT) story when it was a gold project with an increadibly good lithium future.